Safety and immunogenicity of a pediatric formulation of inactivated hepatitis A vaccine in Argentinean children

Pediatric Infectious Disease Journal

Volumn 20, Issue 1, 2001, Pages 48-52

  López, Eduardo L ^a,c   Del Carmen Xifró, María ^a   Torrado, Lidia E ^a   Fabiana De Rosa, María ^a   Gómez, Roberto ^b   Dumas, Rafaele ^b   Wood, Susan C ^b   Marta Contrini, María ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^b SANOFI PASTEUR   (France)

^c NONE   (Argentina)

Author keywords

Argentinean children; Hepatitis A vaccine; Immunogenicity

Indexed keywords

ANTIGEN; HEPATITIS A VACCINE; INACTIVATED VACCINE;

ADOLESCENT; ANTIBODY TITER; ARGENTINA; ARTICLE; CHILD; DOSE RESPONSE; DRUG FORMULATION; DRUG SAFETY; FEVER; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADOLESCENT; ARGENTINA; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS ANTIBODIES; HEPATOVIRUS; HUMANS; IMMUNIZATION, SECONDARY; INFANT; MALE; SAFETY; VACCINES, INACTIVATED;

EID: 0035152332     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200101000-00009     Document Type: Article

References (19)

1. Hepatitis A in Latin America: A changing epidemiologic pattern
2. Clinical development of a new, inactivated hepatitis A vaccine
3. Health control of hepatitis A: Memorandum from a WHO meeting
4. Who should receive hepatitis A vaccines?
5. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
6. Prevention of hepatitis A through active or passive immunization: Recommendation of the Advisory Committee on Immunization Practices (ACIP)
7. Prevention of hepatitis A infections: Guidelines for use of hepatitis A vaccine and immune globulin
8. Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine
9. Sensitive assays for hepatitis A antibodies
10. Immunoprecipitation and virus neutralization assays demonstrate qualitative differences between protective antibody responses to inactivated hepatitis A vaccine and passive immunization with immune globulin
11. Clinical experience with an inactivated hepatitis A vaccine
12. Immunogenicity of an inactivated hepatitis A vaccine in Alaska Native children and non-Native adults
13. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children
14. Safety and Immunogenicity of hepatitis A vaccine in healthy children
15. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children
16. Protection against hepatitis A by an inactivated vaccine
17. Safety Immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 years old children
18. Immunogenicity of inactivated hepatitis A vaccine in children
19. Safety and immunogenicity of an inactivated hepatitis A vaccine in Argentinian children